CAMBRIDGE, United Kingdom and NEW YORK, October 13, 2025 – Artios Pharma Limited (“Artios”), a biopharmaceutical company committed to realizing the therapeutic power of targeting the DNA damage ...
DNA repair proteins act like the body's editors, constantly finding and reversing damage to our genetic code. Researchers have long struggled to understand how cancer cells hijack one of these ...
– Independent prospective analysis validates theta-band inter-trial coherence (ITC) as an important, objective measure to distinguish patients with schizophrenia from healthy individuals – – A ...
Researchers in Milan have described how a protein makes cancer cells resistant to radio and chemotherapy. They also showed that this protein is targeted by a drug currently in clinical trials, that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback